Connect with us
[ad_1] Dave Sekera, Morningstar's Chief U.S. Market Strategist says the best value is in the small cap category. [ad_2] Source link
[ad_1] Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson‘s and Bristol Myers Squibb‘s legal challenges...
[ad_1] CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care conference in San Francisco. Taking...
[ad_1] (This is CNBC Pro’s live coverage of Wednesday’s analyst calls and Wall Street chatter. Please refresh every 20-30 minutes to view the latest posts.) Wednesday’s...
[ad_1] Here are the most important news items that investors need to start their trading day: 1. Bond yield boost U.S. stock futures slid Monday morning...
[ad_1] Bristol Myers Squibb Co. said Sunday it will buy Mirati Therapeutics Inc. in a deal valued at up to $5.8 billion. The pharmaceutical giant announced...
[ad_1] A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey |...
[ad_1] Traders work on the floor of the New York Stock Exchange during morning trading, April 10, 2023. Michael M. Santiago | Getty Images The pharmaceutical...
[ad_1] Bristol Myers Squibb on Friday sued the Biden administration over Medicare‘s new powers to slash drug prices, the third such lawsuit to be filed against...
[ad_1] Investors are preparing for a gloomy 2023 by doubling down on cash-rich companies . “We prefer companies generating cash rather than those that need capital...